Isolation and characterisation of human monoclonal antibodies specific to antigens expressed in cancer
type: CreativeWork
author: Bujak, Emil
language: en
keywords: MONOKLONALE ANTIKÖRPER (IMMUNOLOGISCHE TECHNIKEN); ANTIKÖRPERTECHNIKEN (IMMUNOLOGISCHE TECHNIKEN); ZIELGERICHTETE ARZNEIMITTEL (PHARMAKOLOGIE); THROMBOSPONDIN (PROTEINE UND PEPTIDE); KREBSHEMMENDE ARZNEIMITTEL (PHARMAZIE); ARZNEIMITTELENTWICKLUNG + ARZNEIMITTELDESIGN + ARZNEIMITTELENTDECKUNG; MONOCLONAL ANTIBODIES (IMMUNOLOGICAL TECHNIQUES); ANTIBODY TECHNIQUES (IMMUNOLOGICAL TECHNIQUES); TARGETED DRUGS (PHARMACOLOGY); THROMBOSPONDIN (PROTEINS AND PEPTIDES); CARCINOSTATICS + ANTINEOPLASTICS + ONCOSTATICS + CANCER REMEDIES (PHARMACY); DRUG DEVELOPMENT + DRUG DESIGN + DRUG DISCOVERY (PHARMACY), info:eu-repo/classification/ddc/610, Medical sciences, medicine
license: http://rightsstatements.org/page/InC-NC/1.0/
date published: 2015
date modified: 2026-07-27T19:28:46Z
provider: ETH Zürich
publisher: Networked Digital Library of Theses and Dissertations
type: WebPage
source organization: ETH Zurich

PropertyValue
property ID: Handle
value: http://hdl.handle.net/20.500.11850/154983

PropertyValue
property ID: DOI
value: 10.3929/ethz-a-010399730